Literature DB >> 1683907

Taxol: twenty years later, the story unfolds.

E K Rowinsky, R C Donehower.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1683907     DOI: 10.1093/jnci/83.24.1778

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

1.  The quandary of experimental chemotherapy.

Authors:  B Modan
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

2.  Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice.

Authors:  Jin-Hui Yuan; Ru-Ping Zhang; Ru-Gang Zhang; Li-Xia Guo; Xing-Wang Wang; Dan Luo; Yong Xie; Hong Xie
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

Review 3.  Taccalonolides: Novel microtubule stabilizers with clinical potential.

Authors:  April L Risinger; Susan L Mooberry
Journal:  Cancer Lett       Date:  2009-10-31       Impact factor: 8.679

4.  Paclitaxel plus platinum or gemcitabine plus platinum in first-line treatment of advanced non-small-cell lung cancer: results from 6 randomized controlled trials.

Authors:  Jingwei Jiang; Xiaohua Liang; Xinli Zhou; Ruofan Huang; Zhaohui Chu; Qiong Zhan
Journal:  Int J Clin Oncol       Date:  2012-12-06       Impact factor: 3.402

Review 5.  Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.

Authors:  C M Spencer; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

6.  Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel.

Authors:  H L Lin; T Y Liu; C W Wu; C W Chi
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

Review 7.  Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy - non-mitotic mechanisms of paclitaxel.

Authors:  Elizabeth R Smith; Marilyn Huang; Matthew P Schlumbrecht; Sophia H L George; Xiang-Xi Xu
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

8.  Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro.

Authors:  A P Jekunen; R D Christen; D R Shalinsky; S B Howell
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

9.  Phase I and pharmacokinetic study of paclitaxel by 24-hour intravenous infusion.

Authors:  T Tamura; Y Sasaki; K Eguchi; T Shinkai; Y Ohe; M Nishio; H Kunikane; H Arioka; A Karato; H Omatsu
Journal:  Jpn J Cancer Res       Date:  1994-10

10.  Reversal of Taxol resistance in hepatoma by cyclosporin A: involvement of the PI-3 kinase-AKT 1 pathway.

Authors:  H-L Lin; W-Y Lui; T-Y Liu; C-W Chi
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.